4
Changes in Ownership
OptimizeRx Corp Filed Acc 0001628280-25-044540
Chief Product & Tech Officer gave up 983 shares (to pay taxes)
- Chief Product & Tech Officer acquired 3,325 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Besch Doug Chief Product & Tech Officer | 2025-10-03 | Option exercise | +3,325 | 70,555 | D | ||
| Besch Doug Chief Product & Tech Officer | 2025-10-03 | Shares withheld for taxes | −983 | $18.75 | $18,431 | 69,572 | D |
| Derivatives | |||||||
| Besch Doug Chief Product & Tech Officer | 2025-10-03 | Option exercise · Restricted Stock Units | −3,325 | 0 | D | ||
Loading xslF345X05/wk-form4_1759873941.xml…